These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11422748)

  • 1. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides.
    El-Koraie AF; Baddour NM; Adam AG; El Kashef EH; El Nahas AM
    Kidney Int; 2001 Jul; 60(1):167-72. PubMed ID: 11422748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell factor and crescentic glomerulonephritis.
    El Kossi MM; El Nahas AM
    Am J Kidney Dis; 2003 Apr; 41(4):785-95. PubMed ID: 12666065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of mast cells, stem cell factor and protease-activated receptor-2 in tubulointerstitial lesions in IgA nephropathy.
    Liu H; Liu F; Peng Y; Liu Y; Li L; Tu X; Cheng M; Xu X; Chen X; Ling G; Sun L
    Inflamm Res; 2010 Jul; 59(7):551-9. PubMed ID: 20131076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cells and tubulointerstitial fibrosis in patients with ANCA-associated glomerulonephritis.
    Otsubo S; Nitta K; Uchida K; Yumura W; Nihei H
    Clin Exp Nephrol; 2003 Mar; 7(1):41-7. PubMed ID: 14586742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased expression of mast cells in reflux nephropathy.
    Solari V; Unemoto K; Piaseczna Piotrowska A; Puri P
    Pediatr Nephrol; 2004 Feb; 19(2):157-63. PubMed ID: 14677055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased density of interstitial mast cells in amyloid A renal amyloidosis.
    Tóth T; Tóth-Jakatics R; Jimi S; Takebayashi S
    Mod Pathol; 2000 Sep; 13(9):1020-8. PubMed ID: 11007043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cell chymase expression and mast cell phenotypes in human rejected kidneys.
    Yamada M; Ueda M; Naruko T; Tanabe S; Han YS; Ikura Y; Ogami M; Takai S; Miyazaki M
    Kidney Int; 2001 Apr; 59(4):1374-81. PubMed ID: 11260398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cells in rapidly progressive glomerulonephritis.
    Tóth T; Tóth-Jakatics R; Jimi S; Ihara M; Urata H; Takebayashi S
    J Am Soc Nephrol; 1999 Jul; 10(7):1498-505. PubMed ID: 10405205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cells in acute cellular rejection of human renal allografts.
    Lajoie G; Nadasdy T; Laszik Z; Blick KE; Silva FG
    Mod Pathol; 1996 Dec; 9(12):1118-25. PubMed ID: 8972470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: role of transmembrane SCF and the PAR-2/PKC-α/Raf-1/p44/42 signaling pathway.
    Wygrecka M; Dahal BK; Kosanovic D; Petersen F; Taborski B; von Gerlach S; Didiasova M; Zakrzewicz D; Preissner KT; Schermuly RT; Markart P
    Am J Pathol; 2013 Jun; 182(6):2094-108. PubMed ID: 23562441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of stem cell factor (SCF) and SCF receptor (c-kit) in synovial membrane in arthritis: correlation with synovial mast cell hyperplasia and inflammation.
    Ceponis A; Konttinen YT; Takagi M; Xu JW; Sorsa T; Matucci-Cerinic M; Santavirta S; Bankl HC; Valent P
    J Rheumatol; 1998 Dec; 25(12):2304-14. PubMed ID: 9858422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cells in chronic rejection of human renal allografts.
    Pardo J; Diaz L; Errasti P; Idoate M; de Alava E; Sola I; Lozano L; Panizo A
    Virchows Arch; 2000 Aug; 437(2):167-72. PubMed ID: 10993277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell factor in a rat model of serum nephrotoxic nephritis.
    El Kossi MM; Haylor JL; Johnson TS; El Nahas AM
    Nephron Exp Nephrol; 2008; 108(1):e1-e10. PubMed ID: 18087173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early human renal allograft fibrosis: cellular mediators.
    Abo-Zenah H; Katsoudas S; Wild G; de Takats D; Shortland J; Brown CB; El Nahas AM
    Nephron; 2002 May; 91(1):112-9. PubMed ID: 12021527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.
    Ehara T; Shigematsu H
    Kidney Int; 1998 Nov; 54(5):1675-83. PubMed ID: 9844144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.
    Sellge G; Lorentz A; Gebhardt T; Levi-Schaffer F; Bektas H; Manns MP; Schuppan D; Bischoff SC
    J Immunol; 2004 Jan; 172(1):260-7. PubMed ID: 14688333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib stimulates human skin type mast cell degranulation and maturation.
    Mizukami Y; Sugawara K; Kira Y; Tsuruta D
    J Dermatol Sci; 2017 Dec; 88(3):308-319. PubMed ID: 28843624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
    Li L; Meng XW; Krilis SA
    J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant expression of stem cell factor on biliary epithelial cells and peribiliary infiltration of c-kit-expressing mast cells in hepatolithiasis and primary sclerosing cholangitis: a possible contribution to bile duct fibrosis.
    Tsuneyama K; Kono N; Yamashiro M; Kouda W; Sabit A; Sasaki M; Nakanuma Y
    J Pathol; 1999 Dec; 189(4):609-14. PubMed ID: 10629565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of stem cell factor dependent formation of human mast cells by interleukin-3 and interleukin-4.
    Sillaber C; Sperr WR; Agis H; Spanblöchl E; Lechner K; Valent P
    Int Arch Allergy Immunol; 1994 Nov; 105(3):264-8. PubMed ID: 7522690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.